首页> 外文期刊>European review for medical and pharmacological sciences. >Advances in biochemical mechanisms of diabetic retinopathy.
【24h】

Advances in biochemical mechanisms of diabetic retinopathy.

机译:糖尿病视网膜病变生化机制研究进展。

获取原文
获取原文并翻译 | 示例
       

摘要

Diabetes mellitus is a major cause of blindness in the working population of the Western World. Numerous large, prospective, randomized clinical trials have delineated the current standard prevention and treatment protocols including intensive glycemic and blood pressure control as well as laser photocoagulation for clinically significant macular edema and/or proliferative retinopathy at a high risk for tractional retinal detachment. However, despite all these interventions, vision loss from diabetic retinopathy still occurs at an alarming rate and no data provide an adequate explanation for the serious and rapid involvement of the retinal microcirculation that may be observed in the disease despite a good metabolic control. In fact, there is now ample of evidence that the development of diabetic retinopathy is a multifactorial process where genetic, metabolic and growth factors play an important role. Some biochemical mechanisms, supposed to be involved in the pathogenesis of diabetic retinopathy, have been highlighted in this review.
机译:糖尿病是西方世界劳动人口失明的主要原因。许多大型的,前瞻性,随机的临床试验已经描述了当前的标准预防和治疗方案,包括加强血糖和血压控制以及激光光凝治疗黄斑水肿和/或增生性视网膜病变,这些视网膜黄斑水肿和/或增生性视网膜病具有高度的牵引性视网膜脱离风险。然而,尽管采取了所有这些干预措施,糖尿病性视网膜病的视力丧失仍然以惊人的速度发生,并且尽管有良好的代谢控制,也没有数据为该疾病中观察到的视网膜微循环的严重和快速受累提供充分的解释。实际上,现在有大量证据表明,糖尿病性视网膜病的发展是一个多因素过程,其中遗传,代谢和生长因子起着重要作用。在这篇综述中强调了一些可能与糖尿病性视网膜病的发病机制有关的生化机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号